|
1
|
Xiong J, Xue FS, Yuan YJ, Wang Q, Liao X
and Wang WL: Cholinergic anti-inflammatory pathway: a possible
approach to protect against myocardial ischemia reperfusion injury.
Chin Med J (Engl). 123:2720–2726. 2010.PubMed/NCBI
|
|
2
|
Naidu BV, Farivar AS, Woolley SM, Grainger
D, Verrier ED and Mulligan MS: Novel broad-spectrum chemokine
inhibitor protects against lung ischemia-reperfusion injury. J
Heart Lung Transplant. 23:128–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roupe KA, Remsberg CM, Yáñez JA and Davies
NM: Pharmacometrics of stilbenes: seguing towards the clinic. Curr
Clin Pharmacol. 1:81–101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin HS, Yue BD and Ho PC: Determination of
pterostilbene in rat plasma by a simple HPLC-UV method and its
application in pre-clinical pharmacokinetic study. Biomed
Chromatogr. 23:1308–1315. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kapetanovic IM, Muzzio M, Huang Z,
Thompson TN and McCormick DL: Pharmacokinetics, oral
bioavailability, and metabolic profile of resveratrol and its
dimethylether analog, pterostilbene, in rats. Cancer Chemother
Pharmacol. 68:593–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perecko T, Drabikova K, Rackova L, et al:
Molecular targets of the natural antioxidant pterostilbene: effect
on protein kinase C, caspase-3 and apoptosis in human neutrophils
in vitro. Neuro Endocrinol Lett. 31(Suppl 2): 84–90.
2010.PubMed/NCBI
|
|
7
|
Athar M, Back JH, Tang X, et al:
Resveratrol: a review of preclinical studies for human cancer
prevention. Toxicol Appl Pharmacol. 224:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McCormack D and McFadden D: A review of
pterostilbene antioxidant activity and disease modification. Oxid
Med Cell Longev. 2013:5754822013.PubMed/NCBI
|
|
9
|
McCormack D and McFadden D: Pterostilbene
and cancer: current review. J Surg Res. 173:e53–e61. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Black SC and Rodger IW: Methods for
studying experimental myocardial ischemic and reperfusion injury. J
Pharmacol Toxicol Methods. 35:179–190. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Speyer CL and Ward PA: Role of endothelial
chemokines and their receptors during inflammation. J Invest Surg.
24:18–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khimenko PL, Bagby GJ, Fuseler J and
Taylor AE: Tumor necrosis factor-alpha in ischemia and reperfusion
injury in rat lungs. J Appl Physiol (1985). 85:2005–2011.
1998.PubMed/NCBI
|
|
13
|
Batista ML Jr, Rosa JC, Lopes RD, et al:
Exercise training changes IL-10/TNF-alpha ratio in the skeletal
muscle of post-MI rats. Cytokine. 49:102–108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu J, Liu M, Kennedy RH and Liu SJ:
TNF-alpha-induced impairment of mitochondrial integrity and
apoptosis mediated by caspase-8 in adult ventricular myocytes.
Cytokine. 34:96–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meldrum DR, Cleveland JC Jr, Cain BS, Meng
X and Harken AH: Increased myocardial tumor necrosis factor-alpha
in a crystalloid-perfused model of cardiac ischemia-reperfusion
injury. Ann Thorac Surg. 65:439–443. 1998. View Article : Google Scholar
|
|
16
|
Gurevitch J, Frolkis I, Yuhas Y, et al:
Anti-tumor necrosis factor-alpha improves myocardial recovery after
ischemia and reperfusion. J Am Coll Cardiol. 30:1554–1561. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lefer AM, Ma XL, Weyrich A and Lefer DJ:
Endothelial dysfunction and neutrophil adherence as critical events
in the development of reperfusion injury. Agents Actions Suppl.
41:127–135. 1993.PubMed/NCBI
|
|
18
|
Ma XL, Lefer DJ, Lefer AM and Rothlein R:
Coronary endothelial and cardiac protective effects of a monoclonal
antibody to intercellular adhesion molecule-1 in myocardial
ischemia and reperfusion. Circulation. 86:937–946. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chandrasekar B, Smith JB and Freeman GL:
Ischemia-reperfusion of rat myocardium activates nuclear
factor-KappaB and induces neutrophil infiltration via
lipopolysaccharide-induced CXC chemokine. Circulation.
103:2296–2302. 2001. View Article : Google Scholar
|
|
20
|
Liu P, Hock CE, Nagele R and Wong PY:
Formation of nitric oxide, superoxide, and peroxynitrite in
myocardial ischemia-reperfusion injury in rats. Am J Physiol.
272:H2327–H2336. 1997.PubMed/NCBI
|
|
21
|
Li J, Wu F, Zhang H, et al: Insulin
inhibits leukocyte-endothelium adherence via an Akt-NO-dependent
mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol.
47:512–519. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Zhang H, Wu F, et al: Insulin
inhibits tumor necrosis factor-alpha induction in myocardial
ischemia/reperfusion: role of Akt and endothelial nitric oxide
synthase phosphorylation. Crit Care Med. 36:1551–1558. 2008.
View Article : Google Scholar
|
